Bolt Biotherapeutics (BOLT) Stock Chart & Stock Price History $5.62 +0.10 (+1.72%) As of 02:14 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOwnershipShort InterestTrendsBuy This Stock Bolt Biotherapeutics Stock Price Performance The Bolt Biotherapeutics (BOLT) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 61.91%, with a year-to-date return of -47.44%. In the past month, the stock has decreased 7.77%, reflecting recent market activity. As of the latest close, Bolt Biotherapeutics traded at $5.53 with a market cap of $10.62 million and volume of 9,259 shares. Receive BOLT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Bolt Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-3.18%1 Month Performance-7.77%3 Month Performance-20.44%Year-To-Date Performance-47.44%1 Year Performance-61.91% BOLT Stock Chart for Monday, August, 4, 2025 BOLT Chart by TradingView Bolt Biotherapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization08/01/2025$5.65$5.53-2.12%$5.59$5.309,259 shs$10.62 million07/31/2025$5.81$5.65-2.75%$6.14$5.5128,417 shs$10.83 million07/30/2025$6.13$5.81-5.22%$6.11$5.8130,319 shs$11.16 million07/29/2025$6.30$6.13-2.70%$6.34$6.048,559 shs$11.77 million07/28/2025$6.32$6.30-0.32%$6.49$6.1316,358 shs$12.08 million07/25/2025$6.60$6.32-4.24%$6.60$6.294,463 shs$12.12 million07/24/2025$6.71$6.60-1.64%$6.80$6.3721,564 shs$12.67 million07/23/2025$5.95$6.71+12.77%$6.87$6.1351,341 shs$12.88 million07/22/2025$5.74$5.95+3.66%$6.29$5.6126,490 shs$11.41 million07/21/2025$5.53$5.74+3.80%$5.89$5.5037,984 shs$11.02 million Get the Latest News and Ratings for BOLT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Bolt Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/18/2025$5.74$5.53-3.66%$5.79$5.5321,711 shs$10.62 million07/17/2025$5.74$5.74$5.87$5.703,255 shs$11.02 million07/16/2025$5.70$5.74+0.70%$5.87$5.6226,487 shs$11.00 million07/15/2025$5.96$5.70-4.36%$6.03$5.6515,531 shs$10.94 million07/14/2025$6.19$5.96-3.72%$6.16$5.6554,117 shs$11.44 million07/11/2025$6.32$6.19-2.06%$6.24$6.0415,024 shs$11.89 million07/10/2025$6.22$6.32+1.61%$6.40$6.1523,935 shs$12.13 million07/09/2025$6.04$6.22+2.98%$6.30$6.099,179 shs$11.92 million07/08/2025$5.87$6.04+2.90%$6.22$5.7916,843 shs$11.60 million07/07/2025$6.10$5.87-3.75%$6.00$5.6834,710 shs$11.27 million07/04/2025$6.10$6.10$6.04$5.91928 shs$11.71 million07/03/2025$5.91$6.10+3.20%$6.04$5.91928 shs$11.71 million Related Companies SAB Biotherapeutics Stock Price Chart Curis Stock Price Chart Amgen Stock Price Chart Gilead Sciences Stock Price Chart Vertex Pharmaceuticals Stock Price Chart Regeneron Pharmaceuticals Stock Price Chart Alnylam Pharmaceuticals Stock Price Chart Biogen Stock Price Chart United Therapeutics Stock Price Chart Incyte Stock Price Chart Receive BOLT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Bolt Biotherapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:BOLT) was last updated on 8/4/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | SponsoredProtect Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredI’d rather trade news like this than gamble on hypeReal traders are watching Nvidia’s next move—after U.S. approval to resume chip sales to China. This reversal ...Timothy Sykes | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredOne stock to replace NvidiaInvesting Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bolt Biotherapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Bolt Biotherapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
